Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma

European Journal of Medicinal Chemistry
2019.0

Abstract

Nineteen organoselenides were synthesized and tested for their intrinsic cytotoxicity in hepatocellular carcinoma (HepG2) and breast adenocarcinoma (MCF-7) cell lines and their corresponding selective cytotoxicity (SI) was estimated using normal lung fibroblast (WI-38) cells. Most of the organic selenides exhibited good anticancer activity, and this was more pronounced in HepG2 cells. Interestingly, the naphthoquinone- (5), thiazol- (12), and the azo-based (13) organic selenides demonstrated promising SI (up to 76). Furthermore, the amine 4c, naphthoquinone 5, and azo-based 13 and 15 organic selenides were able to down-regulate the expression of Bcl-2 and up-regulate the expression levels of IL-2, IL-6 and CD40 in HepG2 cells compared to untreated cells. Moreover, most of the synthesized candidates manifested good free radical-scavenging and GPx-like activities comparable to vitamin C and ebselen. The obtained results suggested that some of the presented organoselenium candidates have promising anti-HepG2 and antioxidant activities.

Knowledge Graph

Similar Paper

Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma
European Journal of Medicinal Chemistry 2019.0
Combinatorial synthesis, in silico , molecular and biochemical studies of tetrazole-derived organic selenides with increased selectivity against hepatocellular carcinoma
European Journal of Medicinal Chemistry 2016.0
Synthesis and biological evaluation of organoselenium (NSAIDs-SeCN and SeCF3) derivatives as potential anticancer agents
European Journal of Medicinal Chemistry 2020.0
Organoselenocyanates and symmetrical diselenides redox modulators: Design, synthesis and biological evaluation
European Journal of Medicinal Chemistry 2015.0
New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations
European Journal of Medicinal Chemistry 2021.0
Exploring a synthetic organoselenium compound for antioxidant pharmacotherapy—toxicity and effects on ROS-production
Bioorganic & Medicinal Chemistry 2010.0
Heterocycles 23: Synthesis, characterization and anticancer activity of new hydrazinoselenazole derivatives
Medicinal Chemistry Research 2013.0
Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents
Journal of Medicinal Chemistry 2016.0
Novel selenadiazole derivatives as selective antitumor and radical scavenging agents
European Journal of Medicinal Chemistry 2018.0
Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates
European Journal of Medicinal Chemistry 2011.0